ConductScience.org, home
Papers
API referenceFor AI assistants

Paper42327770

Chronic spontaneous cholinergic urticaria: advances in immunological mechanisms focusing on neuro-immune crosstalk and novel targeted therapeutic strategies.

Yang M and 5 others. Front Immunol, 2026. Cited by 0 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Chronic spontaneous cholinergic urticaria: advances in immunological mechanisms focusing on neuro-immune crosstalk and novel targeted therapeutic strategies. Papers, record 42327770. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42327770

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Chronic spontaneous cholinergic urticaria: advances in immunological mechanisms focusing on neuro-immune crosstalk and novel targeted therapeutic strategies.
PubMed
Journal
Front Immunol
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yang MMeilv
2Lin SSuxian
3Lu YYang
4Jin HHuanzhi
5Zhang XXueliang
6Chen ZZheyan

Source PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Chronic UrticariaMajor topic
NeuroimmunomodulationMajor topic
Humans
Mast Cells
Animals
Cytokines
Signal Transduction
Molecular Targeted Therapy

Source PubMed

References104

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
139,424,194Validation of the Cholinergic Urticaria Activity Score (CholUAS).J Allergy Clin Immunol Pract2025https://conductscience.org/library/papers/39424194PubMed
235,967,390Impaired sweating in patients with cholinergic urticaria is linked to low expression of acetylcholine receptor CHRM3 and acetylcholine esterase in sweat glands.Front Immunol2022https://conductscience.org/library/papers/35967390PubMed
341,497,012A new era in chronic spontaneous urticaria: FDA approval of the oral BTK inhibitor remibrutinib.Ann Med Surg (Lond)2026https://conductscience.org/library/papers/41497012PubMed
432,565,175Direct and indirect action modes of acetylcholine in cholinergic urticaria.Allergol Int2021https://conductscience.org/library/papers/32565175PubMed
536,107,396Cholinergic Urticaria: Subtype Classification and Clinical Approach.Am J Clin Dermatol2023https://conductscience.org/library/papers/36107396PubMed
640,782,271Autoallergy and what the Allergist Needs to know.Curr Allergy Asthma Rep2025https://conductscience.org/library/papers/40782271PubMed
735,315,137Anhidrosis accompanied by cholinergic urticaria-like rash and dermal pain in a patient with Sjögren's syndrome.J Dermatol2022https://conductscience.org/library/papers/35315137PubMed
838,892,164Thymic Stromal Lymphopoietin and Tezepelumab in Airway Diseases: From Physiological Role to Target Therapy.Int J Mol Sci2024https://conductscience.org/library/papers/38892164PubMed
939,051,334A Comparison of Natural and Therapeutic Anti-IgE Antibodies.Antibodies (Basel)2024https://conductscience.org/library/papers/39051334PubMed
1036,457,600Cholinergic Urticaria: A Case Report.Cureus2022https://conductscience.org/library/papers/36457600PubMed
1134,954,198An open-label, proof-of-concept study of lirentelimab for antihistamine-resistant chronic spontaneous and inducible urticaria.J Allergy Clin Immunol2022https://conductscience.org/library/papers/34954198PubMed
1238,431,226Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials.J Allergy Clin Immunol2024https://conductscience.org/library/papers/38431226PubMed
1335,210,803Cholinergic Urticaria, an Effective and Safe "Off Label" Use of Dupilumab: A Case Report with Literature Review.Clin Cosmet Investig Dermatol2022https://conductscience.org/library/papers/35210803PubMed
1440,266,575Rilzabrutinib in Antihistamine-Refractory Chronic Spontaneous Urticaria: The RILECSU Phase 2 Randomized Clinical Trial.JAMA Dermatol2025https://conductscience.org/library/papers/40266575PubMed
1537,176,575Neuro-Immuno-Psychological Aspects of Chronic Urticaria.J Clin Med2023https://conductscience.org/library/papers/37176575PubMed
1632,115,683Co-occurrence of IgE and IgG autoantibodies in patients with chronic spontaneous urticaria.Clin Exp Immunol2020https://conductscience.org/library/papers/32115683PubMed
1736,264,653Biologics for chronic spontaneous urticaria: toward a personalized treatment.Expert Rev Clin Immunol2022https://conductscience.org/library/papers/36264653PubMed
1836,109,590Urticaria.Nat Rev Dis Primers2022https://conductscience.org/library/papers/36109590PubMed
1939,004,090Chronic urticaria: unmet needs, emerging drugs, and new perspectives on personalised treatment.Lancet2024https://conductscience.org/library/papers/39004090PubMed
2039,955,696Implications of nociceptor receptors and immune modulation: emerging therapeutic targets for autoimmune diseases.Inflammopharmacology2025https://conductscience.org/library/papers/39955696PubMed

See all 104 references

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
IGHE3,497PubTator's text mininghttps://conductscience.org/library/genes/3497NCBI Gene
IL133,596PubTator's text mininghttps://conductscience.org/library/genes/3596NCBI Gene
IL43,565PubTator's text mininghttps://conductscience.org/library/genes/3565NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42327770

GET https://conductscience.org/api/papers/v1/42327770/references?page=2

API referenceFor AI assistants